← Open Payments lookup

KELLY COLONELLO: Open Payments

NPI 1952396442 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$742 in 24 payments from 12 companies in 2025. Trend: 2023 $1,006 · 2024 $569 · 2025 $742

Food & beverage: $742
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP2$184
GlaxoSmithKline, LLC.4$113
Genmab U.S., Inc.3$98
Sumitomo Pharma America, Inc.2$58
ABBVIE INC.3$57
Eisai Inc.3$56
Astellas Pharma US Inc2$52
Verastem, Inc.1$28
Merck Sharp & Dohme LLC1$27
Baxter Healthcare1$26

Products named: LYNPARZA, Tivdak, JEMPERLI, MYFEMBREE, Lenvima, Veozah, EPKINLY, AVMAPKI FAKZYNJA CO-PACK.

Industry payments across AZ — which companies pay providers there.